Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E19.09 EPS (ttm)2.49 Insider Own23.19% Shs Outstand6.69M Perf Week0.32%
Market Cap326.26M Forward P/E10.99 EPS next Y4.32 Insider Trans5.13% Shs Float5.28M Perf Month7.23%
Income19.58M PEG- EPS next Q0.73 Inst Own51.79% Short Float4.13% Perf Quarter21.46%
Sales66.92M P/S4.88 EPS this Y92.18% Inst Trans40.29% Short Ratio3.93 Perf Half Y77.80%
Book/sh10.52 P/B4.51 EPS next Y25.58% ROA27.90% Short Interest0.22M Perf Year123.06%
Cash/sh8.16 P/C5.82 EPS next 5Y- ROE31.80% 52W Range19.12 - 53.38 Perf YTD7.23%
Dividend Est.- P/FCF19.67 EPS past 5Y- ROI27.63% 52W High-11.03% Beta0.94
Dividend TTM- Quick Ratio7.45 Sales past 5Y28.64% Gross Margin92.86% 52W Low148.38% ATR (14)2.15
Dividend Ex-Date- Current Ratio7.51 EPS Y/Y TTM55.99% Oper. Margin35.79% RSI (14)52.01 Volatility4.44% 4.87%
Employees127 Debt/Eq0.00 Sales Y/Y TTM22.94% Profit Margin29.26% Recom1.00 Target Price65.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q52.40% Payout0.00% Rel Volume0.95 Prev Close47.17
Sales Surprise7.34% EPS Surprise10.94% Sales Q/Q16.15% EarningsMar 05 AMC Avg Volume55.49K Price47.49
SMA20-0.03% SMA503.60% SMA20041.91% Trades Volume52,723 Change0.68%
Date Action Analyst Rating Change Price Target Change
Nov-02-22Downgrade B. Riley Securities Buy → Neutral $60 → $45
Feb-21-24 08:03AM
Feb-19-24 11:14AM
Nov-11-23 10:48AM
Nov-09-23 04:01PM
Oct-26-23 04:01PM
01:08PM Loading…
Sep-14-23 01:08PM
Aug-31-23 04:01PM
Aug-10-23 04:01PM
Jul-28-23 08:03AM
Jul-11-23 08:03AM
Jun-23-23 04:01PM
May-10-23 04:01PM
May-01-23 04:01PM
Apr-28-23 04:01PM
Apr-19-23 04:01PM
08:03AM Loading…
Apr-05-23 08:03AM
Apr-03-23 08:01AM
Mar-21-23 04:05PM
Mar-10-23 08:03AM
Mar-01-23 04:01PM
Dec-14-22 08:03AM
Dec-12-22 08:05AM
Nov-01-22 04:01PM
Oct-19-22 04:01PM
Aug-31-22 08:03AM
Aug-16-22 06:35AM
Aug-02-22 04:01PM
Jul-21-22 08:03AM
Jun-30-22 07:48AM
10:31AM Loading…
May-23-22 10:31AM
May-05-22 10:10AM
May-02-22 07:15PM
Apr-19-22 08:03AM
Apr-07-22 08:03AM
Mar-30-22 03:43PM
Mar-14-22 04:01PM
Mar-01-22 08:01AM
Feb-28-22 04:01PM
Feb-17-22 08:03AM
Jan-25-22 05:38PM
Jan-21-22 08:59AM
Jan-19-22 09:38AM
Dec-28-21 09:38AM
Dec-21-21 09:38AM
Dec-16-21 10:58AM
Dec-08-21 09:38AM
Nov-01-21 04:01PM
Oct-22-21 08:03AM
Oct-15-21 06:58AM
Sep-30-21 12:40PM
Sep-27-21 08:03AM
Sep-06-21 08:46AM
Aug-27-21 09:19AM
Aug-26-21 08:03AM
Aug-17-21 10:08AM
Aug-02-21 07:25PM
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers' patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SEMLER ERICDirectorSep 13Buy28.1126,868755,25977,771Sep 13 07:05 PM
SEMLER ERICDirectorSep 12Buy27.7025,903717,51350,903Sep 13 07:05 PM
SEMLER ERICDirectorSep 11Buy26.9825,000674,50025,000Sep 13 07:05 PM